Hair samples were obtained 1–5 months after ingestion of the antimicrobial ofloxacin, which had been given for 1 or 3 days at the commencement of haloperidol administration, or when its dosage was reduced. The axial distribution of ofloxacin, haloperidol and its active metabolite, reduced haloperidol, was analysed in segments from single strands of hair. Ofloxacin was detected where the content of haloperidol and reduced haloperidol along the hair shaft showed a sharp change, corresponding to the change in dose.
When we matched the time scale of the dosage history to the growth rate, which was estimated using ofloxacin as the time marker, the distribution of the haloperidol and reduced haloperidol precisely coincided with the rise and fall in the dose of haloperidol.
These findings demonstrate that ofloxacin can serve as a time marker when drug distribution along the hair shaft is used to obtain the drug exposure history of an individual.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Senofonte O, Violante N, Fornarelli L, Beccaloni E, Powar A, Caroli S (1989) Reference values for elements of toxicological, clinical and environmental interest in hair of urban subjects. Ann Inst Sup Sanita 25: 385–392
Arnold W (1990) The determination of drugs and their substitutes in human hairs. Forensic Sci Int 46: 17–18
Moeller MR (1992) Drug detection in hair by chromatographic procedures. J Chromatogr 580: 125–134
Uematsu T (1993) Therapeutic Drug Monitoring in Hair Samples. Clin Pharmacokinet 25: 83–87
Uematsu T, Sato R, Suzuki K, Yamaguchi S, Nakashima M (1989) Human scalp hair as evidence of individual dosage history of haloperidol: Method and retrospective study. Eur J Clin Pharmacol 37: 239–244
Sato R, Uematsu T, Sato R, Yamaguchi S, Nakashima M (1989) Human scalp hair as evidence of individual dosage history of haloperidol: Prospective study. Ther Drug Monit 11: 686–691
Uematsu T, Sato R (1990) Human scalp hair as evidence of individual dosage history of haloperidol: Longer-term follow-up study. Ther Drug Mont 12: 582–583
Uematsu T, Sato R, Fujimori O, Nakashima M (1990) Human scalp hair as evidence of individual dosage history of haloperidol: A possible linkage of haloperidol extraction into hair with hair pigment. Arch Dermatol Res 282: 120–125
Matsuno H, Uematsu T, Nakashima M (1990) The measurement of haloperidol and reduced haloperidol in hair as index of dosage history. Br J Clin Pharmacol 29: 187–194
Uematsu T, Yamada K, Matsuno H, Nakashima M (1991) The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol. Ther Drug Monit 13: 183–187
Uematsu T, Matsuno H, Sato H, Hirayama H, Hasegawa K, Nakashima M (1992) Steady-state pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients: analysis of factors determining their concentrations in hair. J Pharm Sci 81: 1008–1011
Miyazawa N, Uematsu T, Mizuno A, Nagashima S, Nakashima M (1991) Ofloxacin in human hair determined by high performance liquid chromatography. Forensic Sci Int 51: 65–77
Uematsu T, Miyazawa N, Nakashima M (1991) The measurement of ofloxacin in hair as an index of exposure. Eur J Clin Pharmacol 40: 581–584
Uematsu T, Miyazawa N, Okazaki O, Nakashima M (1992a) Possible effects of pigment on the pharmacokinetics of ofloxacin and its excretion in hair. J Pharm Sci 81: 45–48
Miyazawa N, Uematsu T (1992) Analysis of ofloxacin in hair as a measure of hair growth and as a time marker for hair analysis. Ther Drug Monit 14: 525–528
Uematsu T, Nakano M, Akiyama H, Nakashima M (1993) The measurement of a new antimicrobial quinolone in hair as an index of drug exposure. Br J Clin Pharmacol 35: 199–203
Mizuno A, Uematsu T, Oshima A, Nakamura M, Nakashima M (1993) Analysis of nicotine content of hair for assessing individual cigarette-smoking behavior. Ther Drug Monit 15: 99–104
Sato H, Uematsu T, Yamada K, Nakashima M (1993) Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol. Eur J Clin Pharmacol 44: 439–444
Uematsu T, Kondo K, Yano S, Yamaguchi S, Nakashima M (1994) The measurement of temafloxacin in human scalp hair as an index of drug exposure. J Pharm Sci 83: 42–45
Barnman JM, Astore I, Pecorato V (1965) The normal tricogram of the adult. J Invest Dermatol 44: 233–239
Barth JH (1986) Measurement of hair growth. Clin Exp Dermatol 11: 127–138
Katz SA, Chatt A (1988) Hair analysis: applications in the biomedical and environmental sciences. VCH Weinheim New York
Eddington ND, Young D (1988) Sensitive electrochemical high-performance liquid chromatography assay for the simultaneous determination of haloperidol and reduced haloperidol. J Pharm Sci 77: 541–543
Saitoh M, Uzuka M, Sakamoto M, Kobori T (1967) Rate of hair growth. In: Montagna W, Robson RL (eds) Advances in biology of the skin. Pergamon Press, New York, pp 183–201
Kligman AM (1961) Pathologic dynamics of human hair loss. I. Telogen effluvium. Arch Dermatol 83: 175–180
Montagna W, Parakkal PF (1974) The structure and function of skin. Academic Press, New York
Myers RJ, Hamilton JB (1951) Regeneration and rate of growth of hairs in men. Ann N Y Acad Sci 53: 562–569
Masuta S, Sakai M, Fujisawa R, Aoki K, Kuroiwa Y (1989) Clinical application of hair protein glycation in the assessment of blood glucose control and diabetic neuropathy. Kobe J Med Sci 35: 1–9
About this article
Cite this article
Nakano, M., Sato, H., Kosuge, K. et al. Using ofloxacin as a time marker in hair analysis for monitoring the dosage history of haloperidol. Eur J Clin Pharmacol 47, 195–202 (1994). https://doi.org/10.1007/BF00194972
- Scalp hair
- time marker
- dosage history